Charles Marc Samama
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Charles Marc Samama has a total of 112 co-authors. Here are the top co-authors by number of shared publications:
Pierre Coriat
3 shared publicationsE Kieffer
2 shared publications- Gilles Godet
Department of Anesthesiology and Intensive Care, and Vascular Surgery Unit, 36684 Pontchaillou University Hospital, Rennes, France
2 shared publications J.F. Hardy
Centre Hospitalier de L'Universite de Montreal, Montreal, Quebec, Canada
2 shared publications- Jean-François Schved
Hemophilia Treatment Center, Montpellier University Hospital, Montpellier, France
2 shared publications Jean-Jacques Guillosson
Professor and Chairman, Emergency Biology Laboratory
2 shared publications
Latest Publications
- 12 July 2011
- Published by Wiley in Vox Sanguinis
- Vol. 101 (2) , 154-174
Prevention and treatment of coagulopathy in patients receiving massive transfusions
- 12 July 2011
- Published by Wiley in Vox Sanguinis
- Vol. 101 (2) , 154-174
Prevention and treatment of coagulopathy in patients receiving massive transfusions
- 1 June 2006
- Vol. 72 (6) , 447-52
Perioperative platelet transfusion. Recommendations of the French Health Products Safety Agency (AFSSAPS) 2003.
The aim of this paper is to present the recommendations of the Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSaPS; French Safety Agency for Health Products). A panel of experts reviewed and graded the literature on platelet transfusions; recommendations were formulated. Threshold platelet counts (PC) for transfusions in the perioperative context have not been clearly defined and should be determined by the existence of hemorrhagic risk factors. In the case of commonly practiced invasive procedures, the recommendation is to transfuse in order to achieve PC > 50,000 x microL-1. In the absence of platelet dysfunction, regardless of the type of surgery, the standard hemorrhagic risk threshold for surgery is 50,000 x microL-1. It has not been proven that the risk threshold is different according to the type of surgery. For neurosurgery and ophthalmologic surgery involving the posterior segment of the eye, a PC of 100,000 x microL-11 is required. For axial regional anesthesia, a PC of 50,000 x microL-11 is sufficient for spinal anesthesia; a PC of 80,000 x microL-11 has been proposed for epidurals. During massive transfusion, prophylactic platelet infusion cannot be recommended beyond a loss of two blood volumes in less than 24 h (Professional Consensus). As for the therapeutic transfusion of plasma and/or platelets, as much as possible, platelet deficit should be documented with test results (PC and fibrinogen) before transfusing. In the event of bleeding, platelet transfusion may precede plasma infusion. However, although this recommendation has been the subject of several professional consensus agreements, it is not based on any randomized studies. Threshold PC for perioperative transfusions have not been clearly defined and most recommendations are the result of a professional consensus.
- 1 June 2006
- Vol. 72 (6) , 447-52
Perioperative platelet transfusion. Recommendations of the French Health Products Safety Agency (AFSSAPS) 2003.
The aim of this paper is to present the recommendations of the Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSaPS; French Safety Agency for Health Products). A panel of experts reviewed and graded the literature on platelet transfusions; recommendations were formulated. Threshold platelet counts (PC) for transfusions in the perioperative context have not been clearly defined and should be determined by the existence of hemorrhagic risk factors. In the case of commonly practiced invasive procedures, the recommendation is to transfuse in order to achieve PC > 50,000 x microL-1. In the absence of platelet dysfunction, regardless of the type of surgery, the standard hemorrhagic risk threshold for surgery is 50,000 x microL-1. It has not been proven that the risk threshold is different according to the type of surgery. For neurosurgery and ophthalmologic surgery involving the posterior segment of the eye, a PC of 100,000 x microL-11 is required. For axial regional anesthesia, a PC of 50,000 x microL-11 is sufficient for spinal anesthesia; a PC of 80,000 x microL-11 has been proposed for epidurals. During massive transfusion, prophylactic platelet infusion cannot be recommended beyond a loss of two blood volumes in less than 24 h (Professional Consensus). As for the therapeutic transfusion of plasma and/or platelets, as much as possible, platelet deficit should be documented with test results (PC and fibrinogen) before transfusing. In the event of bleeding, platelet transfusion may precede plasma infusion. However, although this recommendation has been the subject of several professional consensus agreements, it is not based on any randomized studies. Threshold PC for perioperative transfusions have not been clearly defined and most recommendations are the result of a professional consensus.
- 1 April 2006
- Published by Springer Nature in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
- Vol. 53 (4) , 336-338
Preemptive use of recombinant activated factor VII: many questions but few answers
- 1 April 2006
- Published by Springer Nature in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
- Vol. 53 (4) , 336-338
Preemptive use of recombinant activated factor VII: many questions but few answers
- 1 April 2006
- Published by Wolters Kluwer Health in European Journal of Anaesthesiology
- Vol. 23 (4) , 355-356
Tracheal intubation with and without muscular relaxation
- 1 April 2006
- Published by Wolters Kluwer Health in European Journal of Anaesthesiology
- Vol. 23 (4) , 355-356
Tracheal intubation with and without muscular relaxation
- 1 August 2005
- Published by Elsevier in Annales Françaises d'Anesthésie et de Réanimation
- Vol. 24 (8) , 853-861
Prévention de la maladie thromboembolique veineuse périopératoire et obstétricale
- 1 August 2005
- Published by Elsevier in Annales Françaises d'Anesthésie et de Réanimation
- Vol. 24 (8) , 853-861
Prévention de la maladie thromboembolique veineuse périopératoire et obstétricale
- 1 January 2005
- Published by Springer Nature in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
- Vol. 52 (1) , 30-37
Perioperative platelet transfusion: recommendations of the Agence française de sécurité sanitaire des produits de santé (AFSSaPS) 2003
To present the recommendations of the Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSaPS; French Safety Agency for Health Products). A panel of experts reviewed and graded the literature on platelet transfusions; recommendations were formulated. Threshold platelet counts (PC) for transfusions in the perioperative context have not been clearly defined and should be determined by the existence of hemorrhagic risk factors. In the case of commonly practiced invasive procedures, the recommendation is to transfuse in orderto achieve PC > 50,000 · μL−1. In the absence of platelet dysfunction, regardless of the type of surgery, the standard hemorrhagic riskthreshold for surgery is 50,000 · μL−1. It has not been proven that the risk threshold is different according to the type of surgery. For neurosurgery and ophthalmologic surgery involving the posterior segment of the eye, a PC of 100,000 · μL−1 is required. For axial regional anesthesia, a PC of 50,000 · μL−1 is sufficient for spinal anesthesia; a PC of 80,000 · μL−1 has been proposed for epidurals. During massive transfusion, prophylactic platelet infusion cannot be recommended beyond a loss of two blood volumes in less than 24 hr (Professional Consensus). As for the therapeutic transfusion of plasma and/or platelets, as much as possible, platelet deficit should be documented with test results (PC and fibrinogen) before transfusing. In the event of bleeding, platelet transfusion may precede plasma infusion. However, although this recommendation has been the subject of several professional consensus agreements, it is not based on any randomized studies. Threshold PC for perioperative transfusions have not been clearly defined and most recommendations are the result of a professional consensus. Présenter les recommandations de l’Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSaPS). Un panel d’experts a revu et évalué la documentation sur les transfusions de plaquettes; des recommandations ont été formulées. Le décompte plaquettaire seuil (DP) pour les transfusions périopératoires n’est pas clairement défini et doit être déterminé par l’existence de facteurs de risque hémorragique. Dans le cas de gestes invasifs pratiqués fréquemment, on recommande de transfuser pour atteindre un DP > 50 000 · μL−1. En l’absence de dysfonction plaquettaire, peu importe le type de chirurgie, le seuil du risque hémorragique normal de la chirurgie est de 50 000 · μL−1. On n’a pas prouvé que le seuil de risque dépend du type de chirurgie. En neurochirurgie, et ophtalmologique touchant le segment postérieur de l’œil, il faut un DP de 100 000 · μ−1. En anesthésie régionale axiale, un DP de 50 000 · μL−1 est suffisant pour la rachianesthésie; un DP de 80 000 · μL−1 a été proposé pour les péridurales. Pendant la transfusion massive, la perfusion prophylactique de plaquettes ne peut être recommandée au delà d’une perte de deux masses sanguines en moins de 24 h (Consensus professionnel). Comme pour la transfusion thérapeutique de plasma et/ou de plaquettes, autant que possible, le déficit de plaquettes doit être documenté avec les résultats de tests (DP et fibrinogène) avant de transfuser. En cas d’hémorragie, la transfusion de plaquettes peut précéder la transfusion de plasma. Cependant, même si cette recommandation a fait l’objet de certains accords du consensus professionnel, il n’est fondé sur aucune étude randomisée. Le DP seuil pour les transfusions périopératoires n’a pas été clairement défini et la plupart des recommandations sont le résultat d’un consensus professionnel.
- 1 January 2005
- Published by Springer Nature in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
- Vol. 52 (1) , 30-37
Perioperative platelet transfusion: recommendations of the Agence française de sécurité sanitaire des produits de santé (AFSSaPS) 2003
To present the recommendations of the Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSaPS; French Safety Agency for Health Products). A panel of experts reviewed and graded the literature on platelet transfusions; recommendations were formulated. Threshold platelet counts (PC) for transfusions in the perioperative context have not been clearly defined and should be determined by the existence of hemorrhagic risk factors. In the case of commonly practiced invasive procedures, the recommendation is to transfuse in orderto achieve PC > 50,000 · μL−1. In the absence of platelet dysfunction, regardless of the type of surgery, the standard hemorrhagic riskthreshold for surgery is 50,000 · μL−1. It has not been proven that the risk threshold is different according to the type of surgery. For neurosurgery and ophthalmologic surgery involving the posterior segment of the eye, a PC of 100,000 · μL−1 is required. For axial regional anesthesia, a PC of 50,000 · μL−1 is sufficient for spinal anesthesia; a PC of 80,000 · μL−1 has been proposed for epidurals. During massive transfusion, prophylactic platelet infusion cannot be recommended beyond a loss of two blood volumes in less than 24 hr (Professional Consensus). As for the therapeutic transfusion of plasma and/or platelets, as much as possible, platelet deficit should be documented with test results (PC and fibrinogen) before transfusing. In the event of bleeding, platelet transfusion may precede plasma infusion. However, although this recommendation has been the subject of several professional consensus agreements, it is not based on any randomized studies. Threshold PC for perioperative transfusions have not been clearly defined and most recommendations are the result of a professional consensus. Présenter les recommandations de l’Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSaPS). Un panel d’experts a revu et évalué la documentation sur les transfusions de plaquettes; des recommandations ont été formulées. Le décompte plaquettaire seuil (DP) pour les transfusions périopératoires n’est pas clairement défini et doit être déterminé par l’existence de facteurs de risque hémorragique. Dans le cas de gestes invasifs pratiqués fréquemment, on recommande de transfuser pour atteindre un DP > 50 000 · μL−1. En l’absence de dysfonction plaquettaire, peu importe le type de chirurgie, le seuil du risque hémorragique normal de la chirurgie est de 50 000 · μL−1. On n’a pas prouvé que le seuil de risque dépend du type de chirurgie. En neurochirurgie, et ophtalmologique touchant le segment postérieur de l’œil, il faut un DP de 100 000 · μ−1. En anesthésie régionale axiale, un DP de 50 000 · μL−1 est suffisant pour la rachianesthésie; un DP de 80 000 · μL−1 a été proposé pour les péridurales. Pendant la transfusion massive, la perfusion prophylactique de plaquettes ne peut être recommandée au delà d’une perte de deux masses sanguines en moins de 24 h (Consensus professionnel). Comme pour la transfusion thérapeutique de plasma et/ou de plaquettes, autant que possible, le déficit de plaquettes doit être documenté avec les résultats de tests (DP et fibrinogène) avant de transfuser. En cas d’hémorragie, la transfusion de plaquettes peut précéder la transfusion de plasma. Cependant, même si cette recommandation a fait l’objet de certains accords du consensus professionnel, il n’est fondé sur aucune étude randomisée. Le DP seuil pour les transfusions périopératoires n’a pas été clairement défini et la plupart des recommandations sont le résultat d’un consensus professionnel.
- 31 December 2004
- Published by Elsevier in Réanimation
- Vol. 13 (8) , 477-483
Transfusion massive et dysfonction hémostatique : physiopathologie et gestion clinique
- 31 December 2004
- Published by Elsevier in Réanimation
- Vol. 13 (8) , 477-483
Transfusion massive et dysfonction hémostatique : physiopathologie et gestion clinique
- 27 November 2004
- Published by Elsevier in Réanimation
- Vol. 13 (8) , 477-483
Transfusion massive et dysfonction hémostatique : physiopathologie et gestion clinique
- 27 November 2004
- Published by Elsevier in Réanimation
- Vol. 13 (8) , 477-483
Transfusion massive et dysfonction hémostatique : physiopathologie et gestion clinique